Efficacy, safety of hydroxychloroquine vs placebo to prevent SARS-CoV-2 infection among health care


What The Study Did:

In this randomized clinical trial, daily hydroxychloroquine didn’t prevent SARS-CoV-2 infection among hospital-based health care workers, although the trial was terminated early.


Authors:

Ravi K. Amaravadi, M.D., of the University of Pennsylvania in Philadelphia, is the corresponding author.


To access the embargoed study:

Visit our For The Media website at this link

https:/

/

media.

jamanetwork.

com/

(doi:10.1001/jamainternmed.2020.6319)


Editor’s Note:

The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

###


Media advisory:

The full study is linked to this news release.


Embed this link to provide your readers free access to the full-text article

This link will be live at the embargo time

https:/

/

jamanetwork.

com/

journals/

jamainternalmedicine/

fullarticle/

10.

1001/

jamainternmed.

2020.

6319?guestAccessKey=

053387bf-8cfb-4ea9-952c-1dd260fd4aed&utm_source=

For_The_Media&utm_medium=

referral&utm_campaign=

ftm_links&utm_content=

tfl&utm_term=

093020

This part of information is sourced from https://www.eurekalert.org/pub_releases/2020-09/jn-eso092920.php

withyou android app